Cases & Deals

  • Home
  • Practices
  • King Pharmaceuticals launches patent infringement action regarding Avinza®

Share

King Pharmaceuticals launches patent infringement action regarding Avinza®

October 2007

Client(s) King Pharmaceuticals, Inc.

Jones Day represents King Pharmaceuticals, Inc. in a Paragraph IV patent infringement litigation involving generic Morphine Sulfate Extended-Release Capsules USP for 30, 60, 90 and 120 mg doses.

King Pharmaceuticals Inc. et al v. Actavis, Inc. et al (2-09-cv-06585) NJD

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.